BioMarin appeases an activist
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: Pharma
STAT+: Pharmalittle: FDA rejects Merck cough medicine; Sanofi abandons an ADC for lung cancer
Good morning, everyone. Damian Garde here, filling in for Ed Silverman in a week customarily…
STAT+: Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace
To ring the register, a pharmaceutical company may create a patent thicket, which involves filing…
STAT+: Medical marijuana companies are using pharma’s sales tactics with little of the same scrutiny
WASHINGTON — Medical marijuana companies sell medicine, just like pharmaceutical companies. But they’re not playing…
STAT+: Drugs are still mostly tested in white men. Will the FDA change that next year?
WASHINGTON — Sometime next year drug and medical device companies will have to tell the…
STAT+: Pharmalittle: Curevac loses key patent in battle with BioNTech; Abernethy to step down as Verily CMO
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Pharmalittle: Curevac loses key patent in battle with BioNTech; Abernathy to step down as Verily CMO
Good morning, everyone, and how are you today? We are doing just fine, thank you….
Morning Rounds: Have regulations on digital trackers in health care gone too far?
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
The biotech updates you need to read today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Weight loss drugs are being paired with bariatric surgery; Carl Icahn plans to oust Illumina directors
Top of the morning to you. And a fine one it is. Lots of sunshine…
STAT+: Wegovy may have another helpful trick: fighting inflammation via the brain, study finds
As more data emerges that obesity drugs like Wegovy can reduce complications from heart and…
The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Illumina will divest Grail after court finds deal was anti-competitive; FDA found problems at Moderna facility
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: ‘We’ve exhausted all avenues’: A small biotech may give up on its ultra-rare disease drug over frustration with FDA
Jamie Dubuque faces the future with a mixture of gratitude and trepidation. Her son, Declan,…
FDA chastens pet companies over antibiotics
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Bluebird claims big insurer will cover its sickle cell therapy; House Republicans threaten to subpoena FDA commish
And so, another working week will soon draw to a close. Not a moment too…
STAT+: In response to criticism, FDA publishes new database of wayward clinical trial sponsors
In a bid toward greater transparency, the U.S. Food and Drug Administration earlier this month…
.jpg)
STAT+: Why FDA product recalls have spiked in recent years
Either American products are getting worse, or scrutiny over their safety is getting tougher. Whichever…
STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are…
Is it time to worry about Moderna?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
A plot to solve the ‘whack-a-mole’ of drug discovery
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Employers hire virtual providers as obesity drug gatekeepers; Vertex non-opioid nerve pain drug succeeds in mid-stage trial
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Late-stage trial supports broader use of Darzalex, blockbuster J&J multiple myeloma drug
SAN DIEGO — Johnson & Johnson’s multiple myeloma therapy, Darzalex, is already a blockbuster. Now…
Morning Rounds: Can you take GLP-1 drugs during pregnancy?
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound
Top of the morning to you. And a fine one it is. Lots of sunshine…
Tome Biosciences goes public today in another biotech megaround
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Sanofi ends deal for a rare disease drug after FTC voices monopoly concerns
In its latest bid to police the pharmaceutical industry, the U.S. Federal Trade Commission sought…
The biotech news you missed from the weekend
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Bluebird’s sickle-cell screwups may prompt a sale; drugmakers raised prices on widely used meds without new clinical evidence
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds
During 2022, drugmakers substantially raised prices on eight widely used medicines without any new clinical…
STAT+: Amid fears of superbugs, sales of antibiotics used in food-producing livestock rose last year
Amid fears of superbugs, the sale of medically important antibiotics given to food-producing livestock rose…
STAT+: Vertex gets a win as Colorado board leaves cystic fibrosis drug off a list of unaffordable medicines
In a win for Vertex Pharmaceuticals, a Colorado state board voted not to place the…
Morning Rounds: 3D-printed organs, antimicrobial resistance in Ukraine, and other major health stories of the day
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
CRISPR is about to make history. Here’s the 5-minute rundown of what to expect
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Biden pharma patent proposal spurs fears; Klobuchar questions company behind price spike of lead poisoning antidote
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Biden proposal targeting pharma patents spurs industry fears and consumer doubts
Will this be a half a loaf? After months of deliberation, the Biden administration on…
Eli Lilly’s latest $1.4 billion deal might come unglued
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: White House takes aim at pharma patents to lower drug prices; Sanofi CEO defends reducing earnings forecast
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
.jpg)
STAT+: ‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices
In 1997, Celgene obtained a key patent for what would become a blockbuster blood cancer…
Most drugmakers have so far ignored looming FTC deadline to withdraw or amend wayward patents
With 10 days to go, only one company has responded to a demand by the…
STAT+: U.S. judge orders Minnesota to pause its drug pricing transparency law over constitutional issues
In a victory for the pharmaceutical industry, a U.S. judge ruled that Minnesota must temporarily…
Morning Rounds: Couples share high blood pressure, and other health stories you should read today
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Why Cerevel Therapeutics has risen 50% in three days without changing anything
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Pfizer is leaving the BIO trade group; CVS drug-pricing plan may not lower costs for consumers
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: Senate panel considers Medicare policy fixes to drug shortages
WASHINGTON — Members of the Senate Finance Committee took their first steps today toward using…
STAT Morning Rounds: The health news you need to read today
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Carmot’s chance of beating the odds in the biotech market just ended
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: CVS to overhaul how it’s paid for drugs; Biden drug-shortage plan won’t expand chemo supplies
Hello, everyone, and how are you today? We are doing just fine, thank you, as…
STAT+: FDA efforts to oversee foreign drug manufacturing remain inadequate to ensure safety, analysis finds
In the wake of the Covid-19 pandemic, the Food and Drug Administration inspected far fewer…
STAT Morning Rounds: Six health news stories you need to start your day
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…